Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0896 USD | +10.89% | +15.91% | -56.08% |
03-26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
03-26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 14.8M 20.32M | Sales 2025 * | 19.28M 26.48M | Capitalization | 3.23M 4.44M |
---|---|---|---|---|---|
Net income 2024 * | -3M -4.12M | Net income 2025 * | - 0 | EV / Sales 2024 * | 0.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
3.58
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on NovaBay Pharmaceuticals
1 day | +10.89% | ||
1 week | +15.91% | ||
Current month | +10.89% | ||
1 month | -14.59% | ||
3 months | -44.55% | ||
6 months | -73.82% | ||
Current year | -56.08% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 0.0896 | +10.89% | 1,306,263 |
24-04-30 | 0.0808 | -2.65% | 1,161,399 |
24-04-29 | 0.083 | +5.33% | 771,012 |
24-04-26 | 0.0788 | +2.34% | 2,535,020 |
24-04-25 | 0.077 | -0.39% | 528,596 |
Delayed Quote Nyse, May 01, 2024 at 04:00 pm
More quotesEPS Revisions
- Stock Market
- Equities
- NBY Stock